In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.
about
Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP massDietary squalene increases high density lipoprotein-cholesterol and paraoxonase 1 and decreases oxidative stress in miceScavenger receptor class B type I: a multifunctional receptor.TNFa alter cholesterol metabolism in human macrophages via PKC-θ-dependent pathwayAlginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis.Adiponectin upregulates ABCA1 expression through liver X receptor alpha signaling pathway in RAW 264.7 macrophages.Cholesterol efflux is LXRα isoform-dependent in human macrophages.Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetesClinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macNifedipine enhances cholesterol efflux in RAW264.7 macrophages.The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses.High-density lipoprotein cholesterol targeting for novel drug discovery: where have we gone wrong?High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters.Consumption of polyunsaturated fat improves the saturated fatty acid-mediated impairment of HDL antioxidant potential.
P2860
Q33933958-C293C507-22CF-4F81-8187-8B3FBABC3208Q34035387-65EF07A8-36BE-4C5B-962A-91A1FF56FCFCQ34246570-5BAA7E75-8EA7-44CC-884E-9EF48C398D42Q34892550-04413787-4BED-4551-9A6B-5398A28042B1Q35014329-B9D01DA6-3745-459D-AEA2-7E331DB97059Q35145079-7C9A5A8D-FF20-45A0-91D5-F894F692CFECQ35201512-72D9C6A6-D3AE-4489-A353-F4E8D3391967Q36500202-21F5B019-2C3E-4222-AE0C-049B0EA04152Q37236276-9A23DDA0-6DC3-4A19-8B5E-23838426D16EQ38956232-BF522C13-C39F-437B-941E-E83F35669DA5Q39132949-A315E739-3D21-4411-A2AD-33451517C12FQ39883075-A505CE36-DE3D-47CB-A098-9F758DC800B9Q41461069-10343D50-19BE-4189-A4CD-B999B829C782Q43498643-12192A01-A811-4EEA-BB37-054CE23CC006Q45840153-AA2E63D4-2A54-40E1-BEEA-CB4FD7DE130BQ46708533-C74CA2A0-934A-4EC4-83F5-DE09D8D6E394
P2860
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@en
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@nl
type
label
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@en
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@nl
prefLabel
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@en
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@nl
P2093
P1433
P1476
In vivo macrophage-specific RC ...... edicting HDL atheroprotection.
@en
P2093
Francisco Blanco-Vaca
Josep Julve
Noemí Rotllan
P304
P356
10.1016/J.ATHEROSCLEROSIS.2008.12.044
P577
2009-03-21T00:00:00Z